
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
Considerations During Development of a Protein A-Based Antibody Purification Process
by Harish Iyer, Felicia Henderson, Eric Cunningham, James Welbb, John Hanson, Christopher Bork, and Lynn Conley, IDEC Pharmaceuticals Corporation Scale-up changes in an antibody purification process can increase final product purity, make the process more robust, and reduce processing time. This case study focuses on the initial purification step -- protein A chromatography -- and offers data collected from several years of process development work on many different antibodies.
Articles in this issue
over 23 years ago
Inside Washington: Biotechnology in the Limelight, the Year Aheadover 23 years ago
Your Vested Interests: The War of the Westover 23 years ago
Statistics for Laboratory Method Comparison Studiesover 23 years ago
Liposomes (a Review): Part Two, Drug Delivery Systemsover 23 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.